As basal B breast cancer cell lines are often associated with tumor invasive and aggressive features, two triple negative breast cancer cell lines, MDA-MB-231 and BT-549 (with baseline PRDX3 expression shown in Figure S1) were selected for further investigations. Here, PRDX3 is linked to breast carcinoma.